Human Single-Chain T Cell Receptors
AssigneeAbbVie Inc.
InventorsDavid M. Kranz, David H. Aggen
Life of this patent
Estimating the term…
Abstract
A soluble human single-chain T cell receptor (TCR) having the structure: Vα2-L-Vβ or Vβ-L-Vα2, wherein L is a linker peptide that links Vβ with Vα, Vβ is a TCR variable β region, and Vα2 is a TCR variable α region of the family 2 is provided. The provided scTCR is useful for many purposes, including the treatment of cancer, viral diseases and autoimmune diseases.
Claims36
A soluble human single-chain T cell receptor (TCR) having the structure:
- Vα2-L-Vβ or Vβ-L-Vα2, wherein L is a linker peptide that links Vβ with Vα, Vβ is a TCR variable β region, and Vα2 is a TCR variable a region of the family 2.
The TCR of any of the preceding claims, further comprising a biologically active group.
A method for producing single-chain T cell receptors comprising expressing a single-chain TCR of any of the preceding claims in E. coli.
An isolated single-chain TCR of any of the preceding claims.
A stable single-chain TCR of Vα-L-Vβ or Vβ-L-Vα form that has been linked to signaling domains that yields an active TCR on the surface of a T cell.
Dependencies are inferred from the claim text.